Product Information
HYDROXYZINE PAM 50 MG CAP is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0820 per EA under NDC 00555030204. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Jun 15, 1984. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Hydroxyzine Pamoate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00555030204
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
HYDROXYZINE PAMOATEApproval Type
Generic (ANDA)
FDA Application
ANDA088487FDA Approved
6/15/1984
TE Code
AB
On Market Since
7/1/1984
Pharmacological Classes
Price Statistics
The NADAC for HYDROXYZINE PAM 50 MG CAP has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 5.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0820 per EA |
|---|---|
| All-time high | $0.1088 (Jul 12, 2023) |
| All-time low | $0.0683 (Apr 17, 2024) |
| 52-week high | $0.0851 |
| 52-week low | $0.0796 |
| Median price | $0.0808 |
| Average price | $0.0827 |
| Largest weekly change | +16.5% (Jan 22, 2014) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of HYDROXYZINE PAM 50 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for HYDROXYZINE PAM 50 MG CAP, manufactured by Teva Pharmaceuticals USA Inc., is $0.0820 per EA (NDC 00555030204), effective Aug 19, 2026.
How has the price of HYDROXYZINE PAM 50 MG CAP changed over time?
Over the history we have for it, the NADAC for HYDROXYZINE PAM 50 MG CAP has risen 5.5%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for HYDROXYZINE PAM 50 MG CAP?
Since Nov 28, 2013, the NADAC for HYDROXYZINE PAM 50 MG CAP has ranged from a low of $0.0683 (Apr 17, 2024) to a high of $0.1088 (Jul 12, 2023), with a median of $0.0808 per EA.
Are there cheaper alternatives to HYDROXYZINE PAM 50 MG CAP?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as HYDROXYZINE PAM 50 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures HYDROXYZINE PAM 50 MG CAP?
HYDROXYZINE PAM 50 MG CAP (NDC 00555030204) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.